Ratings by Leerink Partners (Ami Fadia)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/21/2021 | Pacira Pharmaceuticals | PCRX | Downgrade | Market Perform (Outperform) |
73.34 (22.00) |
-70% | Details | |
| 1/8/2021 | Myovant Sciences Ltd. | MYOV | Downgrade | Market Perform (Outperform) |
25.18 (26.98) |
7.15% | Details | |
| 12/30/2020 | Osmotica | OSMT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/21/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2020 | scPharmaceuticals | SCPH | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/9/2020 | Amneal Pharmaceuticals | AMRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/3/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2020 | Amarin Corporation | AMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2020 | Perrigo Co. | PRGO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2020 | Trevi Therapeutics | TRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | AMAG Pharmaceuticals | AMAG | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/6/2020 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/1/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Mallinckrodt plc | MNK | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/6/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2020 | Amarin Corporation | AMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2020 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2020 | Pacira Pharmaceuticals | PCRX | Upgrade | Outperform (Market Perform) |
32.52 (22.00) |
-32.35% | Details | |
| 3/20/2020 | Perrigo Co. | PRGO | Upgrade | Outperform (Market Perform) |
43.75 (10.72) |
-75.5% | Details | |
| 3/12/2020 | Xeris Pharmaceuticals | XERS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2020 | Endo International plc | ENDP | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/6/2020 | Osmotica | OSMT | New Coverage | Outperform (N/A) |
5.47 (1.11) |
-79.71% | Details | |
| 3/3/2020 | Heron Therapeutics | HRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/27/2020 | Mylan | MYL | Downgrade | Market Perform (Outperform) |
21.85 (15.86) |
-27.41% | Details | |
| 12/13/2019 | Amarin Corporation | AMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/11/2019 | Iterum Therapeutics | ITRM | Downgrade | Market Perform (Outperform) |
3.98 (0.17) |
-95.73% | Details | |
| 12/3/2019 | Ardelyx, Inc | ARDX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2019 | Amarin Corporation | AMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/15/2019 | Trevi Therapeutics | TRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2019 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/7/2019 | Amneal Pharmaceuticals | AMRX | Downgrade | Market Perform (Outperform) |
1.76 (13.24) |
652.27% | Details | |
| 9/24/2019 | Ardelyx, Inc | ARDX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2019 | Amarin Corporation | AMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2019 | Mallinckrodt plc | MNK | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/14/2019 | Amarin Corporation | AMRN | New Coverage | Outperform (N/A) |
14.29 (5.15) |
-63.96% | Details | |
| 8/6/2019 | Heron Therapeutics | HRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2019 | Amneal Pharmaceuticals | AMRX | Upgrade | Outperform (Market Perform) |
3.39 (1.76) |
-48.08% | Details | |
| 7/18/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2019 | Trevi Therapeutics | TRVI | New Coverage | Outperform (N/A) |
9.11 (13.30) |
45.99% | Details | |
| 5/21/2019 | Perrigo Co. | PRGO | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/8/2019 | Impax Laboratories | IPXL | Downgrade | Market Perform (Outperform) |
18.30 (18.30) |
0% | Details | |
| 3/5/2019 | Endo International plc | ENDP | Downgrade | Market Perform (Outperform) |
11.24 (0.29) |
-97.42% | Details | |
| 1/30/2019 | scPharmaceuticals | SCPH | Downgrade | Market Perform (Outperform) |
3.70 (5.67) |
53.24% | Details | |
| 12/24/2018 | Perrigo Co. | PRGO | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/3/2018 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2018 | Amneal Pharmaceuticals | AMRX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2018 | Teva Pharma | TEVA | Upgrade | Market Perform (Underperform) |
21.54 (31.05) |
44.15% | Details | |
| 8/17/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2018 | ObsEva | OBSV | New Coverage | Outperform (N/A) |
13.97 (0.10) |
-99.28% | Details |
